In-Jae Oh
Chonnam National University
H-index: 34
Asia-South Korea
Top articles of In-Jae Oh
Early Diagnosis of Lung Cancer by Detecting Tumor Originated Deoxyribo Nucleic Acid (DNA) Fragments Using Plasma Cell-free DNA Methylome and Fragmentome Profiles
2024/5
Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial
Clinical Cancer Research
2024/4/15
In-Jae Oh
H-Index: 24
Young-Chul Kim
H-Index: 60
Abstract CT252: Nicotinamide in combination with EGFR-TKIs for the treatment of stage IV lung adenocarcinoma with EGFR mutations: A randomized double-blind (Phase IIb) trial
Cancer Research
2024/4/5
In-Jae Oh
H-Index: 24
Young-Chul Kim
H-Index: 60
Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8+ T cells in murine models of inflammation
Nature Communications
2024/4/4
Exploring the therapeutic potential of EGFR retreatment: A comprehensive analysis of T790m (+) conversion and prognosis in lung cancer patients
Cancer Research
2024/3/22
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer
Cancers
2024/1/26
In-Jae Oh
H-Index: 24
Eun Young Kim
H-Index: 19
Blood lymphocytes as a prognostic factor for stage III non-small cell lung cancer with concurrent chemoradiation
Chonnam Medical Journal
2024/1
Young-Chul Kim
H-Index: 60
In-Jae Oh
H-Index: 24
A Phase 2, Multicenter, Single Arm Study to Evaluate the Efficacy of Lazertinib in Patients with NSCLC Who Harboring EGFR T790M Mutation Detected by BALF Liquid Biopsy: Interim …
대한결핵및호흡기학회 추계학술발표초록집
2023
In-Jae Oh
H-Index: 24
Homeostatic Dysregulation of Systemic CD8+ T Cell Compartment in Lung Cancer Patients
bioRxiv
2023
In-Jae Oh
H-Index: 24
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population
Nature communications
2023/5/26
Xiao-Ou Shu
H-Index: 85
Young Tae Kim
H-Index: 31
Wei Zheng
H-Index: 95
Wei Jie Seow
H-Index: 20
Lei Song
H-Index: 6
Wei Hu
H-Index: 1
Qiuyin Cai
H-Index: 61
Yun-Chul Hong
H-Index: 52
Jin Hee Kim
H-Index: 4
Yang Yang
H-Index: 9
Hong Zheng
H-Index: 16
Young-Chul Kim
H-Index: 60
Jiang Chang
H-Index: 5
Harsh Patel
H-Index: 1
Atsushi Takahashi
H-Index: 18
Yoshihiro Minamiya
H-Index: 24
Kenji Takeuchi
H-Index: 16
Hiroyuki Suzuki
H-Index: 8
Jian Su
H-Index: 19
In-Jae Oh
H-Index: 24
Kuan-Yu Chen
H-Index: 2
Jae Yong Park
H-Index: 11
Chen Wu
H-Index: 4
Jianjun Liu
H-Index: 15
Ivan P Gorlov
H-Index: 18
Ping Yang
H-Index: 2
Stephen Lam
H-Index: 4
Angela Risch
H-Index: 31
Paul Brennan
H-Index: 13
John K Field
H-Index: 50
Loic Le Marchand
H-Index: 90
Geoffrey Liu
H-Index: 4
Mikael Johansson
H-Index: 18
Developmental self-reactivity determines the pathogenic Tc17 differentiation potential of naive CD8+ T cells by adjusting endogenous SMAD3 expression
2023/5/1
Clinical Usefulness of Serum KL-6 Test for Predicting Occurrence and Assessing Severity of Treatment-related ILD
2023/5
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial
Cells
2023/4/25
Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection
Cancers
2023/11/30
Young-Chul Kim
H-Index: 60
In-Jae Oh
H-Index: 24
Case Report: A case of ultra-late recurrence of KIF13A-RET fusion non-small cell lung cancer response to selpercatinib
Frontiers in Oncology
2023/4/25
Young-Chul Kim
H-Index: 60
In-Jae Oh
H-Index: 24
Exosome Precipitation by Ionic Strength Modulation: ExoPRISM
ACS Applied Materials & Interfaces
2023/11/28
In-Jae Oh
H-Index: 24
Yoon-Kyoung Cho
H-Index: 32
Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Durvalumab after Chemoradiotherapy: PACIFIC-KR.
Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer
2023/4/19
Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)
Cancers
2023/11/24
In-Jae Oh
H-Index: 24
Jiwon Kim
H-Index: 6
Assessment of tumor mutation burden (TMB) based on whole exome sequencing using extracellular vesicles-derived DNA obtained from bronchoalveolar lavage fluid (BALF) in advanced …
Cancer Research
2023/4/4
In-Jae Oh
H-Index: 24
Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
Translational Lung Cancer Research
2023/11/11